CCfV Associate Director, Dr. Craig McCormick visited Global News Morning to discuss the Dalhousie Medical Research Foundation Molly Appeal, and the Infection, Immunity, Inflammation and Vaccinology’s (I3V), research. To learn more about the Molly Appeal, click here… Read More…
CCfV Researcher, Dr. Janice Graham has been recognized by the Royal Society of Canada (RSC) for her outstanding scholarly, and scientific achievements. Read More…
This event will take place on April 24th at the Halifax Infirmary and Dalhousie University Student Union Building, respectively. Faculty, researchers, trainees, and members of the community are all invited to take part in this educational event. (There is no fee to attend, but registration is required to obtain CME credits.)
Click here to register!
Download the full handbook with abstracts here.
IWK researchers want to protect kids from certain infections before they’re born
Click here to read the CBC news piece on Dr. Lisa Barrett’s research study!
Congratulations to Dr. Janice Graham, who has been chosen for the Weaver-Tremblay Award in Canadian Applied Anthropology in 2016. The Weaver-Tremblay Award is the top honour for Anthropology in Canada. Read More…
This series, jointly organized by the Canadian Immunization Research Network (CIRN) and the Canadian Center for Vaccinology (CCfV), includes one or two presentations each month, available by webinar.
Halifax, Nova Scotia; June 30, 2015 – Immunovaccine Inc. , a clinical stage vaccine and immunotherapy company, today announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine.
The Phase 1 study will evaluate the safety and immune response profile of the DPX-RSV vaccine candidate in healthy adults. The study, conducted at the Canadian Center for Vaccinology (CCfV) in Halifax and led by Joanne Langley, M.D., will enroll 40 healthy adults who are 50 to 64 years of age. Read More…
